Denali Therapeutics Inc. (NASDAQ:DNLI) filed a Form 8-K with the Securities and Exchange Commission on January 06, 2026, disclosing a material event. Denali Therapeutics Inc.'s…
Denali Therapeutics Inc. (NASDAQ:DNLI) filed a Form 8-K with the Securities and Exchange Commission on January 06, 2026, disclosing a material event.
Denali Therapeutics Inc.'s stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.
Current market data
NASDAQ · DNLI
$24.00
Down: -$0.67 · -2.72%
Live quote updated
Keep reading
earnings ·
analyst ·
analyst ·
earnings ·
